Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 15/20 | 0.48 |
| ▸ | ALB | P02768 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29322556 | 0.89 | NOD1 (0.51) | FOLH1ALB | |
| SCHEMBL17378269 | 0.84 | FOLH1 (0.43) | FOLH1ALBALDH1A1 | |
| SCHEMBL18659694 | 0.84 | ALDH1A1 (0.45) | FOLH1ALBALDH1A1 | |
| SCHEMBL16089032 | 0.83 | FOLH1 (0.42) | FOLH1ALBALDH1A1 | |
| SCHEMBL20882013 | 0.83 | FOLH1 (0.52) | FOLH1ALBALDH1A1 | |
| SCHEMBL26504875 | 0.82 | FOLH1 (0.48) | FOLH1ALB | |
| SCHEMBL23824133 | 0.82 | SMN1; SMN2 (0.49) | FOLH1ALBALDH1A1 | |
| SCHEMBL18118446 | 0.82 | FOLH1 (0.48) | FOLH1ALB | |
| SCHEMBL17246791 | 0.82 | FOLH1 (0.53) | FOLH1ALB | |
| SCHEMBL17246432 | 0.82 | FOLH1 (0.44) | FOLH1ALBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110229409-A1 | LINKABLE LEWIS X ANALOGS | BRACCO INTERNATIONAL B.V. (NL) | 2011-09-22 | — | — | US | disclosed |
| US-20080300220-A1 | Linkable Lewis X Analogs | BRACCO INTERNATIONAL B.V. (NL) | 2008-12-04 | — | — | US | disclosed |
| US-7422733-B2 | Linkable sialyl Lewis X analogs | BRACCO INTERNATIONAL B.V. (NL) | 2008-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080300220-A1 | Linkable Lewis X Analogs | SSB, SELPLG, SELL | FOLH1 1521/4885ALB 1233/4885ALDH1A1 1758/4885 |
| US-20110229409-A1 | LINKABLE LEWIS X ANALOGS | SELPLG, SELL, SELE | FOLH1 3223/4885ALB 669/4885ALDH1A1 1892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.